Longboard Pharmaceuticals, Inc. (LBPH)

Longboard Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	14.33	10.78	66.35	55.32
Short-Term Investments	34.17	56.81	40.38	-
Cash & Short-Term Investments	48.5	67.59	106.73	55.32
Cash Growth	-28.25%	-36.67%	92.94%	-
Prepaid Expenses	1.72	2.25	1.66	0.05
Total Current Assets	50.22	69.84	108.38	55.36
Property, Plant & Equipment	0.48	0.75	0.54	-
Long-Term Deferred Charges	-	-	-	0.88
Other Long-Term Assets	-	0.03	0.03	-
Total Assets	50.7	70.62	108.95	56.24
Accounts Payable	1	1.31	1.03	1.21
Accrued Expenses	8.26	7.06	3.91	1.92
Current Portion of Leases	0.48	0.36	0.34	-
Current Income Taxes Payable	0.04	0.03	0.17	-
Total Current Liabilities	9.77	8.76	5.44	3.14
Long-Term Leases	-	0.38	0.19	-
Total Liabilities	9.77	9.15	5.63	3.14
Common Stock	0	0	0	-
Additional Paid-In Capital	181.56	148.3	145.68	11.71
Retained Earnings	-140.56	-86.14	-42.2	-14.4
Comprehensive Income & Other	-0.08	-0.69	-0.16	-
Total Common Equity	40.92	61.47	103.32	-2.69
Shareholders' Equity	40.92	61.47	103.32	53.1
Total Liabilities & Equity	50.7	70.62	108.95	56.24
Total Debt	0.48	0.74	0.52	-
Net Cash (Debt)	48.02	66.85	106.2	55.32
Net Cash Growth	-28.16%	-37.05%	91.99%	-
Net Cash Per Share	2.11	3.90	7.37	14.52
Filing Date Shares Outstanding	36.02	22.97	17.22	3.84
Total Common Shares Outstanding	24.52	17.22	17.22	3.84
Working Capital	40.45	61.07	102.94	52.23
Book Value Per Share	1.67	3.57	6.00	-0.70
Tangible Book Value	40.92	61.47	103.32	-2.69
Tangible Book Value Per Share	1.67	3.57	6.00	-0.70

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q